1.10. Analysis.
Comparison 1: D‐cycloserine versus placebo, Outcome 10: Tolerability of D‐cycloserine assessed with numbers of dropouts at one week post‐treatment
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.